Pfizer Healthcare India Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Pfizer Healthcare India Private Limited Pharmaceutical Export Portfolio Dataset — 2 Products, $2.2M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Pfizer Healthcare India Private Limited — Pharmaceutical Exporter Profile (2026) | 2 Products, $2.2M Trade | TransData Nexus

Pfizer Healthcare India Private Limited

Indian Pharmaceutical Exporter · Cardiovascular Specialist · $2.2M Total Trade · DGFT Verified

Pfizer Healthcare India Private Limited is an Indian pharmaceutical exporter with a total trade value of $2.2M across 2 products in 2 therapeutic categories. Based on 44 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Heparin ($1.6M), Furosemide ($650.0K), .

Pfizer Healthcare India Private Limited — Export Portfolio & Destination Treemap

Pfizer Healthcare India Private Limited pharmaceutical export portfolio — 2 products across 2 therapeutic categories. Source: Indian Customs (DGFT).

Who is Pfizer Healthcare India Private Limited? — Company Overview & Market Position

Pfizer Healthcare India Private Limited, established on November 17, 2009, is a private unlisted company headquartered in Chennai, Tamil Nadu, India. The company is registered under the Corporate Identification Number (CIN) U24232TN2009PTC073563. Its authorized capital stands at ₹8.00 crore, with a paid-up capital of ₹6.93 crore. As of April 4, 2024, Pfizer Healthcare India employed approximately 3,733 professionals. The registered office is located at Emerald Building No. 237, Anna Salai, Chennai, Tamil Nadu, 600006.

What Does Pfizer Healthcare India Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Heparin$1.6M 2Furosemide$650.0K

Pfizer Healthcare India Private Limited Therapeutic Categories — 2 Specializations

Pfizer Healthcare India Private Limited operates across 2 therapeutic categories, with representing the largest segments by export value. The portfolio is concentrated — the top 5 products account for 100% of total exports.

Product Portfolio — Top 2 by Export Value

Pfizer Healthcare India Private Limited exports 2 pharmaceutical products across 2 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Heparin	Cardiovascular	$1.6M	31	0.4%	4
2	Furosemide	Diuretics	$650.0K	13	0.9%	4

Pfizer Healthcare India Private Limited exports 2 pharmaceutical products across 2 therapeutic categories with a total export value of $2.2M. The top category is Cardiovascular (70.5% of portfolio), followed by Diuretics (29.5%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Pfizer Healthcare India Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Pfizer Healthcare India operates manufacturing facilities in Sriperumbudur, Tamil Nadu, within the SIPCOT Industrial Park. The plant specializes in the production of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Specific details regarding production capacities and specialized manufacturing processes are not publicly disclosed.

3Key Leadership

The company's leadership comprises several directors and key managerial personnel. As of the latest available information, the directors include Andrew David Chatfield, Kannan Natarajan, Fiona Kathleen Maccarthy, Andrew Gordon Mc Killop, Wriju Ghosh, and Muralidhar B Sharma. Jayaraman Aparajith serves as the Company Secretary. The exact roles and responsibilities of each director are not specified in the available sources.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Pfizer Healthcare India Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Pfizer Healthcare India Private Limited's export activities are primarily focused on finished pharmaceutical formulations, with a total export value of $2.2 million USD across 44 shipments. The exported products include Heparin and Furosemide, which fall under the therapeutic categories of Cardiovascular and Diuretics, respectively. The company's export portfolio is concentrated, with the top five products accounting for 100% of the export value. Specific details regarding regulatory filings, approvals, and market access status in the US, EU, UK, Australia, and Japan are not publicly available.

2Emerging Markets

Pfizer Healthcare India's export data indicates a focus on markets within the Cardiovascular and Diuretics therapeutic categories. However, specific information regarding the company's presence in emerging markets such as Africa, Latin America, and Southeast Asia, as well as WHO prequalification enabling access, is not publicly disclosed.

3Geographic Strategy

The company's export strategy appears to be concentrated, with a portfolio comprising only two products across two therapeutic categories. This focus may indicate a strategic direction aimed at specialization within these categories. However, the limited diversification could also pose concentration risks, especially if market dynamics shift or if there are regulatory challenges in the target markets.

Pfizer Healthcare India Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Pfizer Healthcare India's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly available. The company's export data does not provide insights into its activities related to the US market.

2WHO & EU GMP

Information regarding Pfizer Healthcare India's WHO prequalification status, EU Good Manufacturing Practice (GMP) certificates, and European Directorate for the Quality of Medicines & HealthCare (EDQM) status is not publicly disclosed. The company's export data does not indicate specific certifications or approvals from these regulatory bodies.

3CDSCO & Indian Regulatory

Pfizer Healthcare India holds manufacturing licenses from the Central Drugs Standard Control Organisation (CDSCO) and has approvals from state drug controllers. The company has also obtained export No Objection Certificates (NOCs) for its products. Specific details regarding these licenses and approvals are not publicly available.

Pfizer Healthcare India Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Pfizer Healthcare India's export portfolio is concentrated in the Cardiovascular and Diuretics therapeutic categories, with Heparin and Furosemide being the primary products. The company's market share in these categories is relatively small, with Heparin at 0.4% and Furosemide at 0.9%. Specific information regarding top competitors in these overlapping categories and a detailed market share comparison are not publicly available.

2Key Differentiators

Pfizer Healthcare India's export portfolio is highly concentrated, with the top five products accounting for 100% of the export value. This focus may allow the company to specialize and achieve efficiencies in production and distribution. However, the lack of diversification could also expose the company to risks associated with market fluctuations and regulatory changes in the target markets.

3Strategic Position

The company's export strategy appears to be focused on finished pharmaceutical formulations in the Cardiovascular and Diuretics therapeutic categories. The limited diversification suggests a strategic direction aimed at specialization within these areas. The future outlook may involve expanding the product portfolio and exploring new markets to mitigate concentration risks and enhance growth opportunities.

Buyer Due Diligence Brief — Evaluating Pfizer Healthcare India Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Pfizer Healthcare India's export data indicates a consistent volume of shipments, with a total export value of $2.2 million USD across 44 shipments. The company's focus on finished pharmaceutical formulations suggests a commitment to quality and compliance with international standards. However, the limited diversification in the product portfolio may impact the company's ability to adapt to changing market demands and regulatory environments.

2Certifications to Verify

Importers should verify the following certifications when considering products from Pfizer Healthcare India:

FDA Approval: Confirm that the products are approved by the US Food and Drug Administration (FDA). Verification can be done through the FDA's official website or by contacting the FDA directly.

WHO-GMP Certification: Ensure that the manufacturing facilities comply with the World Health Organization's Good Manufacturing Practice (GMP) standards. This can be verified by checking the WHO's official website or contacting the organization.

Frequently Asked Questions — Pfizer Healthcare India Private Limited

How many pharmaceutical products does Pfizer Healthcare India Private Limited export from India?

Pfizer Healthcare India Private Limited exports 2 pharmaceutical products across 2 therapeutic categories. The top exports are Heparin ($1.6M), Furosemide ($650.0K). Total export value is $2.2M.

What is Pfizer Healthcare India Private Limited's total pharmaceutical export value?

Pfizer Healthcare India Private Limited's total pharmaceutical export value is $2.2M, based on 44 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Pfizer Healthcare India Private Limited cover?

Pfizer Healthcare India Private Limited exports across 2 therapeutic categories. The largest are Cardiovascular (70.5%, 1 products), Diuretics (29.5%, 1 products).

Get Full Pfizer Healthcare India Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.